TIMP-2-IGFBP7, when combined with clinical information, was an excellent predictor of subclinical AKI in crucially ill COVID-19 patients (AUC: 0.682) (Casas-Aparicio et al. 2022). The gene discussed is IGFBP7; the disease is acute kidney injury.